Article Sidebar
Views pdf: 113
CHARACTERISTICS OF SOME PERIPHERAL BLOOD CELL INDICATORS IN PEOPLE WITH THYROID CANCER DIAGNOSED AT THE CENTRAL ENDOCRINE HOSPITAL
Main Article Content
Abstract
Background: Thyroid cancer receives great attention from society due to the increasing number of cases. Using inflammatory markers as a factor predicting the growth trend of cancer cells in thyroid cancer. In Vietnam, there have not been many studies on the changes in peripheral blood cell indexes in patients with thyroid cancer, thereby helping treating doctors have more important information about thyroid cancer. Research objectives: Characteristics of some peripheral blood cell indices in first-time thyroid cancer patients at the National Endocrinology Hospital from March to August 2023. Subjects and research methods: A cross-sectional descriptive study. The study subjects include 144 patients diagnosed with thyroid cancer for the first time from March 2023 to the end of August 2023. Results: Red blood cell (RBC) count was 4.66± 0.48 T/L, mild anemia accounted for 11.1%. The white blood cell (WBC) count in the study subjects was 7.23 ± 1.88 G/L, the percentage of white blood cells increased in 6.9%, decreased in 1.4%, the average number of mono white blood cells was 0. ,45 ± 0.2 G/L, Mono increased rate accounted for 44.4%, no patient had Mono leukopenia. Platelet count in thyroid cancer patients was 267 ± 63.57 G/L, increased platelets accounted for 2.1%, decreased platelets accounted for 0.7%. Conclusion: There are changes in peripheral blood cell indices in patients with papillary and follicular thyroid cancer. The number of Mono white blood cells increases mainly in patients with thyroid cancer. There was no change in platelet count index in patients
Article Details
Keywords
Thyroid cancer, Peripheral blood cells, Anemia
References
2. Y. Wang, Y. Li, P. Chen, W. Xu, Y. Wu, và G. Che, “Prognostic value of the pretreatment systemic immune-inflammation index (SII) in patients with non-small cell lung cancer: a meta-analysis”, Ann. Transl. Med., vol 7, số p.h 18, 2019.
3. Y. J. Yu và c.s., “Preoperative mean platelet volume and platelet distribution associated with thyroid cancer.”, Neoplasma, vol 64, số p.h 4, tr 594–598, 2017.
4. C. M. Riguetto, I. S. Barreto, F. F. R. Maia, L. V. M. da Assumpção, và D. E. Zantut-Wittmann, “Usefulness of pre-thyroidectomy neutrophil–lymphocyte, platelet–lymphocyte, and monocyte–lymphocyte ratios for discriminating lymph node and distant metastases in differentiated thyroid cancer”, Clinics, vol 76, 2021.
5. C. Offi, R. M. Romano, A. Cangiano, M. F. Pignatelli, G. Candela, và G. Docimo, “Evaluation of LMR, NLR and PLR as predictors of malignancy in indeterminate thyroid nodules”, Acta Otorhinolaryngol. Ital., vol 41, số p.h 6, tr 530, 2021.
6. R. Modica, R. Minotta, A. Liccardi, G. Cannavale, E. Benevento, và A. Colao, “Evaluation of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Systemic Immune–Inflammation Index (SII) as Potential Biomarkers in Patients with Sporadic Medullary Thyroid Cancer (MTC)”, J. Pers. Med., vol 13, số p.h 6, tr 953, 2023.